AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.650
+0.080 (3.11%)
Aug 15, 2025, 4:00 PM - Market closed

AIM ImmunoTech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
71321234593
Upgrade
Market Cap Growth
-61.67%-39.50%-5.77%-49.92%-51.57%-16.26%
Upgrade
Enterprise Value
990-13-842
Upgrade
Last Close Price
2.6519.8043.9931.1992.00179.00
Upgrade
PS Ratio
57.8475.79105.42160.27334.23571.61
Upgrade
PB Ratio
--9.742.080.590.791.52
Upgrade
P/TBV Ratio
--2.950.630.831.58
Upgrade
EV/Sales Ratio
74.1253.431.51--256.30
Upgrade
Debt / Equity Ratio
-0.65-2.220.070.020.000.04
Upgrade
Asset Turnover
0.010.010.010.000.000.00
Upgrade
Quick Ratio
0.230.421.6526.3574.1636.41
Upgrade
Current Ratio
0.270.441.6826.6974.6136.58
Upgrade
Return on Equity (ROE)
-3138.91%-388.69%-118.93%-40.79%-32.37%-38.54%
Upgrade
Return on Assets (ROA)
-98.37%-88.30%-66.64%-25.36%-17.44%-21.77%
Upgrade
Return on Capital (ROIC)
-322.63%-196.60%-79.38%-25.85%-17.68%-22.27%
Upgrade
Earnings Yield
-230.98%-134.44%-136.00%-86.05%-42.39%-15.46%
Upgrade
FCF Yield
-177.91%-115.70%-99.87%-71.66%-31.04%-11.15%
Upgrade
Buyback Yield / Dilution
-25.35%-15.30%-1.12%-1.49%-48.67%-774.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q